| Literature DB >> 33664266 |
Britta Frensch1, Thorsten Lechtenberg1, Michel Kather2, Zeynep Yunt3, Martin Betschart4, Bernd Kammerer2,5, Steffen Lüdeke4, Michael Müller4, Jörn Piel6, Robin Teufel7.
Abstract
The structural complexity and bioactivity of natural products often depend on enzymatic redox tailoring steps. This is exemplified by the generation of the bisbenzannulated [5,6]-spiroketal pharmacophore in the bacterial rubromycin family of aromatic polyketides, which exhibit a wide array of bioactivities such as the inhibition of HIV reverse transcriptase or DNA helicase. Here we elucidate the complex flavoenzyme-driven formation of the rubromycin pharmacophore that is markedly distinct from conventional (bio)synthetic strategies for spiroketal formation. Accordingly, a polycyclic aromatic precursor undergoes extensive enzymatic oxidative rearrangement catalyzed by two flavoprotein monooxygenases and a flavoprotein oxidase that ultimately results in a drastic distortion of the carbon skeleton. The one-pot in vitro reconstitution of the key enzymatic steps as well as the comprehensive characterization of reactive intermediates allow to unravel the intricate underlying reactions, during which four carbon-carbon bonds are broken and two CO2 become eliminated. This work provides detailed insight into perplexing redox tailoring enzymology that sets the stage for the (chemo)enzymatic production and bioengineering of bioactive spiroketal-containing polyketides.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33664266 PMCID: PMC7933358 DOI: 10.1038/s41467-021-21432-9
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919